Commodore Capital LP - 31 Dec 2025 SCHEDULE 13G/A Report for BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value (DRUG)

Filing Manager: Commodore Capital LP
Reporting Manager: Commodore Capital LP
Security: BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value
Symbol: DRUG
Disclosed Ownership: 18,851 shares
Ownership: 0.3%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 16:22:37 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Commodore Capital LP	0.3%	18,851	0	18,851	Michael Kramarz	Managing Partner
Commodore Capital Master LP	0.3%	18,851	0	18,851	Michael Kramarz	Authorized Signatory